101583-3
ESBL by ceftazidime to ceftazidime-clavulanate IC ratio [Interpretation] by based on lab data in Positive blood culture Qualitative
Active
Part Descriptions
LP232452-5 Extended-spectrum beta lactamase by ceftazidime to ceftazidime+clavulanate inhibitory concentration ratio
Extended spectrum beta-lactamase (ESBL) enzymes are resistance enzymes produced by pathogenic organisms such as E. coli and Klebsiella. The presence of ESBLs can be detected by comparing the inhibitory concentration (IC) of a specific antimicrobial, such as cefepime (a 4th generation cephalosporin), cefotaxime, or ceftazidime (both 3rd generation cephalosporins), with the IC of that antimicrobial plus clavulanate, an ESBL inhibitor.
Source: Regenstrief LOINC
LP426925-6 Based on lab data
The method "Based on lab data" is intended to be used when a series or combination of laboratory results are utilized together to arrive at a subsequent single result.
Source: Regenstrief LOINC
Fully-Specified Name
- Component
- Extended-spectrum beta lactamase by ceftazidime to ceftazidime+clavulanate inhibitory concentration ratio
- Property
- Imp
- Time
- Pt
- System
- Bld.pos growth
- Scale
- Ord
- Method
- Based on lab data
Additional Names
- Long Common Name
- ESBL by ceftazidime to ceftazidime-clavulanate IC ratio [Interpretation] by based on lab data in Positive blood culture Qualitative
- Short Name
- ESBL cft to cft-clav IC rto Bd Pos Imp
- Display Name
- ESBL by ceftazidime to ceftazidime-clavulanate IC ratio based on lab data Ql (Pos bld culture) [Interp]
- Consumer Name Alpha Get Info
- ESBL by ceftazidime to ceftazidime-clavulanate IC Ratio, Infected blood
Example Answer List: LL744-4
Source: Regenstrief InstituteAnswer | Code | Score | Answer ID |
---|---|---|---|
Detected | LA11882-0 | ||
Not detected | LA11883-8 |
Basic Attributes
- Class
- ABXBACT
- Type
- Laboratory
- First Released
- Version 2.75
- Last Updated
- Version 2.75 (ADD)
- Order vs. Observation
- Both
Language Variants Get Info
Tag | Language | Translation |
---|---|---|
el-GR | Greek (Greece) | Αναλογία ανασταλτικής συγκέντρωσης β-λακταμάσης εκτεταμένου φάσματος από κεφταζιδίμη προς κεφταζιδίμη+κλαβουλανικό: Synonyms: Imp |
es-ES | Spanish (Spain) | ESBL para la concentración inhibitoria de ceftazidima frente a la de ceftzidima-clavulanico: |
fr-FR | French (France) | Ratio CMI bêta lactamase à spectre élargi ceftazidime/ceftazidime+clavulanate: |
it-IT | Italian (Italy) | Rapporto della concentrazione inibitoria di ceftazidime/ceftazidime e acido clavulanico, beta-lattamici a largo spettro: Synonyms: Impressione/interpretazione di studio Punto nel tempo (episodio) Rapporto della IC di ceftazidime/ceftazidime e aci Sangue Suscettibilità agli antibiotici |
zh-CN | Chinese (China) | 头孢他啶相对于头孢他啶+克拉维酸抑菌浓度比值法超广谱 beta 内酰胺酶: Synonyms: B Betalactamase Beta-内酰胺酶 B-Lactamase B-内酰胺酶 β β内酰胺酶 β-内酰胺酶 β-内酰胺酶抑制剂; |
LOINC Terminology Service (API) using HL7® FHIR® Get Info
Requests to this service require a free LOINC username and password. Below is a sample of the possible capabilities. See the LOINC Terminology Service documentation for more information.
- CodeSystem lookup
- https:
//fhir.loinc.org/CodeSystem/$lookup?system=http: //loinc.org&code=101583-3
LOINC Copyright
Copyright © 2025 Regenstrief Institute, Inc. All Rights Reserved. To the extent included herein, the LOINC table and LOINC codes are copyright © Regenstrief Institute, Inc. and the Logical Observation Identifiers Names and Codes (LOINC) Committee. See https://